Liposomal Formulation Delivers Medication More Effectively

By Mayra Pierce


Nanotechnology is a dynamic branch of science that transforms and manipulates substances on a molecular and even atomic level. Liposomes refer to microscopic cellular bubbles made of materials called phospholipids, which are similar to human cell material and are both attracted to and repelled by water. Liposomal formulation helps create these structures for use in the targeted delivery of medication.

The significance of these very small vesicular forms that are able to enclose molecules soluble in water became apparent soon after being introduced during the 1960s. Pharmacists and research scientists became keenly aware of their potential to improve methods of drug delivery when fighting cancer and other serious illness. They encourage more accurate targeting of malicious cells while avoiding issues that plague other forms of administration.

Unlike most other delivery systems, these formulations do not rely on modes of absorption typical to oral or direct IV administration. Conventional delivery can make it harder to manage the effects of specialized drugs, and one common result is the accumulation of toxic materials in other organs, often causing additional and undesired damage. When the medication is placed inside each bubble-like liposome, release can be more easily controlled.

The molecules of a drug are suspended in water within the structure of the artificial cell, which is surrounded by a manufactured membrane. The formulating process of specifically designed liposomes transforms them into mechanisms ideal for transporting hydrophilic drugs, or those that are attracted to water and dissolve effectively. Current methods produce two primary forms called unilammelar and multilammelar, and subcategories include varying sizes.

The liposomes are made to surround the medications with membranes, and when activated release those molecules into other cells. This can be done by fusing the layers, causing them to interact with adjacent human cells, and releasing medication in the process. Other activation strategies include using specific chemical reactions to encourage molecular diffusion. The end result is a controlled, steady delivery.

This process is not only more effectively managed, but is also bio-compatible with human cells, and leaves no additional toxic residue. Some recently developed types of these capsules can be activated using ultrasound, which increases their efficacy in the locations where they are most needed. Others are dispensed via the respiratory system, and are directly deposited into the lungs and then slowly released, reducing overall toxicity.

It is still comparatively costly to manufacture these microscopic capsules. As practicality increases and research finds new uses and procedures, expenses will probably decrease, but still remain high. As is the case in most newer technologies, there are still many unresolved issues. Some forms of these artificial cells have had problems with wall or membrane leakage, while others have been degraded by oxidation and other natural processes.

Like many medical innovations, liposomes are increasingly being used commercially. They are being called a better way to deliver vitamin, herbal and mineral supplements, and there are popular recipes for the personal creation of dietary supplements. While these uses produce their own controversies, the continued development of better medication delivery systems gives additional hope for advanced treatments.




About the Author:



0 comments:

Post a Comment

Twitter Delicious Facebook Digg http://www.stumbleupon.com/stumbler/weightloss33 Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Facebook Themes